These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2807018)

  • 21. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
    Rice LW; Mark SD; Berkowitz RS; Goff BA; Lage JM
    Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
    Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
    Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival and DNA ploidy in advanced epithelial ovarian cancer.
    Resnik E; Trujillo YP; Taxy JB
    J Surg Oncol; 1997 Apr; 64(4):299-303. PubMed ID: 9142186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study.
    Volm M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1989 Oct; 35(1):84-9. PubMed ID: 2792909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular DNA content and survival in advanced ovarian carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
    Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
    Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
    Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of pleural effusions by flow-cytometric DNA analysis.
    Høstmark J; Vigander T; Skaarland E
    Eur J Respir Dis; 1985 May; 66(5):315-9. PubMed ID: 4018184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
    Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
    Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.
    Sikora J; Dworacki G; Zeromski J
    Lung; 1996; 174(5):303-13. PubMed ID: 8843056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA ploidy of ovarian granulosa cell tumors. Lack of correlation between DNA index or proliferative index and outcome in 40 patients.
    Evans MP; Webb MJ; Gaffey TA; Katzmann JA; Suman VJ; Hu TC
    Cancer; 1995 May; 75(9):2295-8. PubMed ID: 7712440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.
    Bergers E; van Diest PJ; Baak JP
    Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy.
    Zangwill BC; Balsara G; Dunton C; Varello M; Rebane BA; Hernandez E; Atkinson BF
    Cancer; 1993 Apr; 71(7):2261-7. PubMed ID: 8453547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary.
    Bakshi N; Rajwanshi A; Patel F; Ganguly NK
    Anal Quant Cytol Histol; 1998 Jun; 20(3):215-20. PubMed ID: 9642449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.